Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Trulieve Cannabis Corp (OP:TCNNF)

3.800 +0.280 (+7.95%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Trulieve Cannabis Corp

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
1 Underrated Growth Industry That Could Be Well Protected Against Tariffs
Via The Motley Fool
Topics Cannabis Economy Law Enforcement
Cannabis Stock Gainers And Losers From April 8, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For April 4, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For April 3, 2025
Via Benzinga
Topics Cannabis
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry. 
Via Benzinga
Topics Cannabis
What Sparked The Cannabis Stock Rally On Thursday?
Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon." 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 18, 2025
Via Benzinga
Topics Cannabis
Marijuana Stock Movers For March 14, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More
This week's cannabis news: Snoop Dogg expands his cannabis empire, Planet 13 recovers millions, Glass House locks in $50M & top earnings drop. 
Via Benzinga
Topics Cannabis
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More
This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch. 
Via Benzinga
Topics Cannabis Government
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook. 
Via Benzinga
Topics Cannabis
Trulieve Cannabis Q4 Earnings: Revenue Beat, EPS Beat, 10 Dispensaries Added, Management Changes And More
Trulieve reported fourth-quarter revenue of $301 million, beating analyst estimates of $292.64 million, according to Benzinga Pro. The cannabis company reported fourth-quarter adjusted earnings of 2... 
Via Benzinga
Topics Cannabis
This Marijuana Stock Just Shocked Its Investors With a Huge Piece of Good News
Via The Motley Fool
Topics Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo. 
Via Benzinga
Topics Cannabis
'President Trump's Endorsement Represents A Sea Change In Cannabis Policy,' Says Trulieve CEO As Advocacy Groups Join Forces
"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers. 
Via Benzinga
Topics Cannabis Government
Cannabis Legalization Headed For The Ballot Again In Florida: Advocates Launch New Amendment Initiative
Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions. 
Via Benzinga
Topics Cannabis
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop. 
Via Benzinga
Topics Cannabis
7 Magnificent Stocks That Can Double Your Money in 2025
Triple-digit returns may be just a click of the buy button away. 
Via The Motley Fool
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns
New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government... 
Via Benzinga
Topics Cannabis
85% Of Cannabis Companies Report Positive Earnings, But Not All Are Winning - See Who's Leading
85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2. 
Via Benzinga
Topics Cannabis
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. 
Via Benzinga
Topics Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector. 
Via Benzinga
Topics Cannabis
Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?
Florida awards 22 new medical cannabis licenses after 18 months, potentially sparking legal battles as patient numbers exceed 880,000. 
Via Benzinga
Topics Cannabis
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%. 
Via Benzinga
Topics Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.